June 13 (Reuters) - U.S. drugmaker Mylan NV said on Wednesday that U.S. health regulators could not approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug, Advair, and cited "minor deficiencies" with the copycat version.


00


Reuters

Latest News

Los Angeles Times: Number of black players at World Cup is way up, but there's only one black coach

USA Today: Jogger detained after accidental border crossing

USA Today: Sarah Hyland shares photo from hospital

Daily Mail: Lewis Hamilton secures 75th career pole at French Grand Prix

Daily Mail: I'm in constant pain, but I've learned to love every day, says NICCI ROSCOE

Daily Mail: Kendall Jenner slips into a bright yellow bikini as she lounges by the pool in Los Angeles

Daily Mail: Low praises Germany for not panicking as World Cup...

Daily Mail: Harry Kane faces the dreaded giant: Panama defender Roman Torres is out to stop England in World Cup

Daily Mail: Things you missed from World Cup day 10: Rudy takes face full of boot

CTV News: Honouring EPS canine killed in line of duty

CTV News: Fredericton road closures lead to traffic troubles

CTV News: Justice Department gives U.S. Congress new classified documents on Russia probe

USA Today: Larson wins pole at home track in Sonoma; Truex to start 2nd

USA Today: Jogger detained after accidental border crossing

USA Today: Padres starter Lyles scratched with forearm tightness

Daily Mail: Michael Rapaport jokes with NBA stars about 'incident' on plane

Daily Mail: Video: Fans celebrate wildly as Germany scores winning goal against Sweden

Daily Mail: Panama boys may be street kids but I know they can trouble England's stars

Daily Mail: German rewarded for patience, says Loew

Daily Mail: Russian jets strike rebel held town in Syria...

Daily Mail: MI5 terror alert as five jihadi leaders linked to London Bridge attack set to be let out of jail

Daily Mail: Saudi women driving ban ends

Daily Mail: Millions of NHS patients are being denied migrane super drug

14 Related Articles from 2018-06-13